NGUỒN GỐC, PHÂN LOẠI VÀ ỨNG DỤNG AXIT BÉO TRONG ĐIỀU TRỊ UNG THƯ TỪ CÁC NGHIÊN CỨU TIỀN LÂM SÀNG: TỔNG QUAN

Trần Thị Lệ Quyên; Trần Thị Thành Trâm; Hồ Thị Nguyên Sa; Nguyễn Ngọc Hiếu

doi:10.34238/tnu-jst.7239

NGUỒN GỐC, PHÂN LOẠI VÀ ỨNG DỤNG AXIT BÉO TRONG ĐIỀU TRỊ UNG THƯ TỪ CÁC NGHIÊN CỨU TIỀN LÂM SÀNG: TỔNG QUAN

Thông tin bài báo

Ngày nhận bài: 21/01/23 Ngày hoàn thiện: 14/04/23 Ngày đăng: 19/04/23

Các tác giả

1. Trần Thị Lệ Quyên, Trường Đại học Kỹ thuật Y – Dược Đà Nẵng
2. Trần Thị Thành Trâm, Trường Đại học Kỹ thuật Y – Dược Đà Nẵng
3. Hồ Thị Nguyên Sa, Trường Đại học Kỹ thuật Y – Dược Đà Nẵng
4. Nguyễn Ngọc Hiếu , Trường Đại học Duy Tân

Tóm tắt

Ung thư là một nhóm các bệnh liên quan đến sự tăng sinh tế bào một cách mất kiểm soát và là nguyên nhân gây tử vong đứng thứ hai trên thế giới. Đối mặt với gánh nặng ung thư toàn cầu, việc tìm ra các phương pháp điều trị luôn thách thức các nhà nghiên cứu từ trước đến nay. Axit béo được biết đến như một chất có hoạt tính chống ung thư, có khả năng ức chế sự tăng trưởng cũng như quá trình xâm lấn và di căn của các khối u. Nhìn chung, axit béo không bão hòa mang lại nhiều lợi ích và giá trị dinh dưỡng cho bệnh nhân ung thư nói riêng và con người nói chung. Tuy nhiên, nhiều bằng chứng thực nghiệm ngày càng cho thấy vai trò có lợi về mặt dinh dưỡng của axit béo bão hòa đối với sức khỏe con người. Trong tổng quan này, chúng tôi cung cấp các kiến thức liên quan về nguồn gốc, phân loại axit béo dựa trên các cơ sở khác nhau. Các tác giả đã đưa ra những kết quả chứng minh tiềm năng của axit béo bão hòa và không bão hòa trong việc ngăn chặn sự phát triển của tế bào ung thư, cung cấp một góc nhìn mới về giá trị của các axit béo bão hòa trong thực phẩm. Đồng thời, các tác giả cũng tổng hợp các kết quả nghiên cứu về những tác dụng đối lập của axit béo trong điều trị các loại tế bào ác tính khác nhau. Bài tổng quan này nhằm khẳng định vai trò mới của axit béo trong việc ngăn chặn sự phát triển của tế bào ung thư và nâng cao tầm quan trọng của axit béo trong chế độ dinh dưỡng của bệnh nhân.

Từ khóa

Axit béo bão hòa; Axit béo không bão hòa; Hoạt chất chống ung thư; Điều trị ung thư; Ung thư

Toàn văn:

PDF

Tài liệu tham khảo

[1] S. Sarkar et al., "Cancer development, progression, and therapy: an epigenetic overview," International Journal of Molecular Sciences, vol. 14, no. 10, pp. 21087-21113, 2013.

[2] A. R. Yadav and S. K. Mohite, "Cancer-A silent killer: An overview," Asian Journal of Pharmaceutical Research, vol. 10, no. 3, pp. 213-216, 2020.

[3] G. I. Evan and K. H. Vousden, "Proliferation, cell cycle and apoptosis in cancer," Nature, vol. 411, no. 6835, pp. 342-348, 2001.

[4] A. Deshpande, P. Sicinski, and P. W. Hinds, "Cyclins and cdks in development and cancer: a perspective," Oncogene, vol. 24, no. 17, pp. 2909-2915, 2005.

[5] F. Wolf et al., "Magnesium and neoplasia: from carcinogenesis to tumor growth and progression or treatment," Archives of biochemistry and biophysics, vol. 458, no. 1, pp. 24-32, 2007.

[6] R. I. Teleanu, C. Chircov, A. M. Grumezescu, and D. M. Teleanu, "Tumor angiogenesis and anti-angiogenic strategies for cancer treatment," Journal of Clinical medicine, vol. 9, no. 1, p. 84, 2019.

[7] H. Sung et al., "Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries," CA: A cancer Journal for Clinicians, vol. 71, no. 3, pp. 209-249, 2021.

[8] A. M. Afifi, A. M. Saad, M. J. Al‐Husseini, A. O. Elmehrath, D. W. Northfelt, and M. B. Sonbol, "Causes of death after breast cancer diagnosis: A US population‐based analysis," Cancer, vol. 126, no. 7, pp. 1559-1567, 2020.

[9] A. Dewey, C. Baughan, T. P. Dean, B. Higgins, and I. Johnson, "Eicosapentaenoic acid (EPA, an omega‐3 fatty acid from fish oils) for the treatment of cancer cachexia," Cochrane database of systematic reviews, no. 1, pp. CD004597, 2007.

[10] N. Merendino, L. Costantini, L. Manzi, R. Molinari, D. D'Eliseo, and F. Velotti, "Dietary ω-3 polyunsaturated fatty acid DHA: a potential adjuvant in the treatment of cancer," BioMed research international, vol. 2013, pp. 310186, 2013.

[11] L.-S. Kremmyda, E. Tvrzicka, B. Stankova, and A. Zak, "Fatty Acids as Biocompounds: Their Role in Human Metabolism, Health and Disease-A Review. Part 2: Fatty Acid Physiological Roles and Applications in Human Health and Disease," Biomedical Papers of the Medical Faculty of Palacky University in Olomouc, vol. 155, no. 3, pp. 195-218, 2011.

[12] D. P. Rose, "Effects of dietary fatty acids on breast and prostate cancers: evidence from in vitro experiments and animal studies," The American Journal of Clinical nutrition, vol. 66, no. 6, pp. 1513S-1522S, 1997.

[13] C. K. Chow, Fatty acids in foods and their health implications. CRC press, 2007.

[14] C. Beermann, J. Jelinek, T. Reinecker, A. Hauenschild, G. Boehm, and H. Klör, "Short term effects of dietary medium-chain fatty acids and n-3 long-chain polyunsaturated fatty acids on the fat metabolism of healthy volunteers," Lipids in Health and Disease, vol. 2, no. 1, pp. 1-10, 2003.

[15] C. C. Akoh, Food lipids: chemistry, nutrition, and biotechnology. CRC press, 2017.

[16] N. Koundouros and G. Poulogiannis, "Reprogramming of fatty acid metabolism in cancer," British Journal of Cancer, vol. 122, no. 1, pp. 4-22, 2020.

[17] M. Jóźwiak, A. Filipowska, F. Fiorino, and M. Struga, "Anticancer activities of fatty acids and their heterocyclic derivatives," European Journal of Pharmacology, vol. 871, p. 172937, 2020.

[18] M. Takahashi, M. Przetakiewicz, A. Ong, C. Borek, and J. M. Lowenstein, "Effect of ω3 and ω6 fatty acids on transformation of cultured cells by irradiation and transfection," Cancer research, vol. 52, no. 1, pp. 154-162, 1992.

[19] V. Ruiz-Gutiérrez and F. J. Muriana, "Effect of ingestion of thermally oxidized frying oil on desaturase activities and fluidity in rat-liver microsomes," The Journal of Nutritional Biochemistry, vol. 3, no. 2, pp. 75-79, 1992.

[20] M. T. Brinkman, M. R. Karagas, M. S. Zens, A. R. Schned, R. C. Reulen, and M. P. Zeegers, "Intake of α-linolenic acid and other fatty acids in relation to the risk of bladder cancer: results from the New Hampshire case–control study," British Journal of Nutrition, vol. 106, no. 7, pp. 1070-1077, 2011.

[21] V. Chajès, W. Sattler, A. Stranzl, and G. M. Kostner, "Influence of n-3 fatty acids on the growth of human breast cancer cellsin vitro: Relationship to peroxides and Vitamin-E," Breast cancer research and treatment, vol. 34, no. 3, pp. 199-212, 1995.

[22] J. P. Chamberland and H.-S. Moon, "Down-regulation of malignant potential by alpha linolenic acid in human and mouse colon cancer cells," Familial Cancer, vol. 14, no. 1, pp. 25-30, 2015.

[23] L. A. Sauer, R. T. Dauchy, D. E. Blask, J. A. Krause, L. K. Davidson, and E. M. Dauchy, "Eicosapentaenoic acid suppresses cell proliferation in MCF-7 human breast cancer xenografts in nude rats via a pertussis toxin–sensitive signal transduction pathway," The Journal of Nutrition, vol. 135, no. 9, pp. 2124-2129, 2005.

[24] Q.-H. Yao et al., "ω-3 polyunsaturated fatty acids inhibit the proliferation of the lung adenocarcinoma cell line A549 in vitro," Molecular medicine reports, vol. 9, no. 2, pp. 401-406, 2014.

[25] W. W. So, W. N. Liu, and K. N. Leung, "Omega-3 polyunsaturated fatty acids trigger cell cycle arrest and induce apoptosis in human neuroblastoma LA-N-1 cells," Nutrients, vol. 7, no. 8, pp. 6956-6973, 2015.

[26] A. Giros et al., "Regulation of Colorectal Cancer Cell Apoptosis by the n-3 Polyunsaturated Fatty Acids Docosahexaenoic and EicosapentaenoicColorectal Cancer Cell Apoptosis and DHA/EPA," Cancer prevention research, vol. 2, no. 8, pp. 732-742, 2009.

[27] C. Y.-K. Lee et al., "The cell cycle effects of docosahexaenoic acid on human metastatic hepatocellular carcinoma proliferation," International Journal of Oncology, vol. 36, no. 4, pp. 991-998, 2010.

[28] M. E. Begin, G. Ells, and D. F. Horrobin, "Polyunsaturated fatty acid-induced cytotoxicity against tumor cells and its relationship to lipid peroxidation," JNCI: Journal of the National Cancer Institute, vol. 80, no. 3, pp. 188-194, 1988.

[29] S. Vartak, R. McCaw, C. Davis, M. Robbins, and A. Spector, "γ-Linolenic acid (GLA) is cytotoxic to 36B10 malignant rat astrocytoma cells but not to'normal'rat astrocytes," British Journal of Cancer, vol. 77, no. 10, pp. 1612-1620, 1998.

[30] U. N. Das, "Tumoricidal and anti-angiogenic actions of gamma-linolenic acid and its derivatives," Current pharmaceutical biotechnology, vol. 7, no. 6, pp. 457-466, 2006.

[31] L. A. Sauer, R. T. Dauchy, and D. E. Blask, "Mechanism for the antitumor and anticachectic effects of n-3 fatty acids," Cancer Research, vol. 60, no. 18, pp. 5289-5295, 2000.

[32] V. E. Baracos, V. C. Mazurak, and D. W. Ma, "n-3 Polyunsaturated fatty acids throughout the cancer trajectory: influence on disease incidence, progression, response to therapy and cancer-associated cachexia," Nutrition research reviews, vol. 17, no. 2, pp. 177-192, 2004.

[33] Y. Guo, S.-L. Zhu, Y.-K. Wu, Z. He, and Y.-Q. Chen, "Omega-3 free fatty acids attenuate insulin-promoted breast cancer cell proliferation," Nutrition Research, vol. 42, pp. 43-50, 2017.

[34] F. Bianchini, E. Giannoni, S. Serni, P. Chiarugi, and L. Calorini, "22: 6n-3 DHA inhibits differentiation of prostate fibroblasts into myofibroblasts and tumorigenesis," British Journal of Nutrition, vol. 108, no. 12, pp. 2129-2137, 2012.

[35] Y. Sun, X. Jia, L. Hou, X. Liu, and Q. Gao, "Involvement of apoptotic pathways in docosahexaenoic acid-induced benefit in prostate cancer: Pathway-focused gene expression analysis using RT2 Profile PCR Array System," Lipids in health and disease, vol. 16, no. 1, pp. 1-8, 2017.

[36] S. Zhu et al., "Metabolic shift induced by ω-3 PUFAs and rapamycin lead to cancer cell death," Cellular Physiology and Biochemistry, vol. 48, no. 6, pp. 2318-2336, 2018.

[37] A. Alonso, V. Ruiz-Gutierrez, and M. A. Martínez-González, "Monounsaturated fatty acids, olive oil and blood pressure: epidemiological, clinical and experimental evidence," Public health nutrition, vol. 9, no. 2, pp. 251-257, 2006.

[38] H. Sales-Campos, P. Reis de Souza, B. C. Peghini, J. Santana da Silva, and C. R. Cardoso, "An overview of the modulatory effects of oleic acid in health and disease," Mini reviews in medicinal chemistry, vol. 13, no. 2, pp. 201-210, 2013.

[39] L. Girao, A. Ruck, R. Cantrill, and B. Davidson, "The effect of C18 fatty acids on cancer cells in culture," Anticancer Research, vol. 6, no. 2, pp. 241-244, 1986.

[40] M. Hughes-Fulford, Y. Chen, and R. R. Tjandrawinata, "Fatty acid regulates gene expression and growth of human prostate cancer PC-3 cells," Carcinogenesis, vol. 22, no. 5, pp. 701-707, 2001.

[41] J. A. Menendez et al., "Extra-virgin olive oil polyphenols inhibit HER2 (erbB-2)-induced malignant transformation in human breast epithelial cells: relationship between the chemical structures of extra-virgin olive oil secoiridoids and lignans and their inhibitory activities on the tyrosine kinase activity of HER2," International Journal of Oncology, vol. 34, no. 1, pp. 43-51, 2009.

[42] C. Oliveras-Ferraros et al., "Crude phenolic extracts from extra virgin olive oil circumvent de novo breast cancer resistance to HER1/HER2-targeting drugs by inducing GADD45-sensed cellular stress, G2/M arrest and hyperacetylation of Histone H3," International Journal of Oncology, vol. 38, no. 6, pp. 1533-1547, 2011.

[43] F. Giulitti et al., "Anti-tumor effect of oleic acid in hepatocellular carcinoma cell lines via autophagy reduction," Frontiers in Cell and Developmental Biology, vol. 9, p. 629182, 2021.

[44] M. H. Raitt et al., "Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial," Jama, vol. 293, no. 23, pp. 2884-2891, 2005.

[45] J. Song et al., "Trans-vaccenic acid inhibits proliferation and induces apoptosis of human nasopharyngeal carcinoma cells via a mitochondrial-mediated apoptosis pathway," Lipids in Health and Disease, vol. 18, no. 1, pp. 1-9, 2019.

[46] J.-N. Lim et al., "Trans-11 18: 1 vaccenic acid (TVA) has a direct anti-carcinogenic effect on MCF-7 human mammary adenocarcinoma cells," Nutrients, vol. 6, no. 2, pp. 627-636, 2014.

[47] K. Nagy and I.-D. Tiuca, "Importance of fatty acids in physiopathology of human body," in Fatty acids, IntechOpen, 2017.

[48] R. P. Mensink, P. L. Zock, A. D. Kester, and M. B. Katan, "Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials," The American Journal of Clinical nutrition, vol. 77, no. 5, pp. 1146-1155, 2003.

[49] R. P. Mensink and W. H. Organization, "Effects of saturated fatty acids on serum lipids and lipoproteins: a systematic review and regression analysis," World Health Organization. https://apps.who.int/iris/handle/10665/246104, 2016.

[50] M. S. Farvid et al., "Dietary linoleic acid and risk of coronary heart disease: a systematic review and meta-analysis of prospective cohort studies," Circulation, vol. 130, no. 18, pp. 1568-1578, 2014.

[51] N. Bendsen, R. Christensen, E. Bartels, and A. Astrup, "Consumption of industrial and ruminant trans fatty acids and risk of coronary heart disease: a systematic review and meta-analysis of cohort studies," European journal of clinical nutrition, vol. 65, no. 7, pp. 773-783, 2011.

[52] L. Pattayil and H.-T. Balakrishnan-Saraswathi, "In vitro evaluation of apoptotic induction of butyric acid derivatives in colorectal carcinoma cells," Anticancer research, vol. 39, no. 7, pp. 3795-3801, 2019.

[53] A. M. Scott, J. D. Wolchok, and L. J. Old, "Antibody therapy of cancer," Nature reviews cancer, vol. 12, no. 4, pp. 278-287, 2012.

[54] R. Han, O. Nusbaum, X. Chen, and Y. Zhu, "Valeric acid suppresses liver cancer development by acting as a novel HDAC inhibitor," Molecular Therapy-Oncolytics, vol. 19, pp. 8-18, 2020.

[55] A. Narayanan, S. A. Baskaran, M. A. R. Amalaradjou, and K. Venkitanarayanan, "Anticarcinogenic properties of medium chain fatty acids on human colorectal, skin and breast cancer cells in vitro," International Journal of Molecular Sciences, vol. 16, no. 3, pp. 5014-5027, 2015.

[56] R. Lappano et al., "The lauric acid-activated signaling prompts apoptosis in cancer cells," Cell death discovery, vol. 3, no. 1, pp. 1-9, 2017.

[57] S. Zhu et al., "Palmitic acid inhibits prostate cancer cell proliferation and metastasis by suppressing the PI3K/Akt pathway," Life Sciences, vol. 286, p. 120046, 2021.

[58] M. Montecillo-Aguado et al., "Omega-6 Polyunsaturated Fatty Acids Enhance Tumor Aggressiveness in Experimental Lung Cancer Model: Important Role of Oxylipins," International Journal of Molecular Sciences, vol. 23, no. 11, p. 6179, 2022.

[59] C.-J. Shen et al., "Oleic acid-induced NOX4 is dependent on ANGPTL4 expression to promote human colorectal cancer metastasis," Theranostics, vol. 10, no. 16, p. 7083, 2020.

[60] H. Y. Kwan et al., "Signal transducer and activator of transcription-3 drives the high-fat diet-associated prostate cancer growth," Cell death & disease, vol. 10, no. 9, p. 637, 2019.

[61] G. Pascual et al., "Targeting metastasis-initiating cells through the fatty acid receptor CD36," Nature, vol. 541, no. 7635, pp. 41-45, 2017.

"Times New Roman",serif;mso-fareast-font-family:Calibri;mso-fareast-theme-font:

minor-latin;mso-ansi-language:PT-BR;mso-fareast-language:EN-US;mso-bidi-language:

AR-SA'>

DOI: https://doi.org/10.34238/tnu-jst.7239

Các bài báo tham chiếu

Hiện tại không có bài báo tham chiếu



Ghi nhớ